Filing Details
- Accession Number:
- 0001209191-20-013392
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-27 16:06:49
- Reporting Period:
- 2020-02-25
- Accepted Time:
- 2020-02-27 16:06:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124105 | Catalyst Biosciences Inc. | CBIO | Pharmaceutical Preparations (2834) | 562020050 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1800097 | M.d. Geoffrey Ling | C/O Catalyst Biosciences, Inc. 611 Gateway Blvd. Suite 710 South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-25 | 3,000 | $6.23 | 3,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
